Amyris (AMRS) Misses Q3 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 falls from record high as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Amyris Reports Third Quarter 2015 Financial Results
November 5, 2015 4:09 PM ESTSigned multi-year Technology Investment Agreement with Defense Advanced Research Projects Agency (DARPA) with contract value of approximately $35 million Q3 2015 revenues of $8.6 million were in line with the company's expected range and after adjusting for once yearly initial production of a fragrance ingredient is more comparable to Q3 2014. The company's second F&F ingredient is expected to ship in Q4 2015 and positively impact Q4 revenues. Achieved record low farnesene manufacturing cash cost of $1.75 per liter in September 2015 Expecting record fourth-quarter 2015 product revenue
EMERYVILLE, Calif., Nov. 5, 2015 (GLOBE NEWSWIRE) -- Amyris, Inc. (Nasdaq:... More
